Arterial Blood Sampling Systems Market Size & Share, by End User (Hospitals, Diagnostic Labs, Ambulatory Surgical Centers (ASCs); Technology; Product; Application – Global Supply & Demand Analysis, Growth Forecasts, Statistical Report 2025-2037

Arterial Blood Sampling Systems Market - Regional Analysis

North America Market Insights

North America in the arterial blood sampling systems market is anticipated to dominate with a share of 42.5% by the end of 2037, with a growth rate of 6.5%. The U.S. readily accounts for 90.5% of the overall regional revenue share, effectively fueled by an expansion in the ICU capacity, technological innovations in automated analyzers, and the existence of Medicare reimbursement policies. As stated in a report published by the CDC, more than 74% of hospitals in the U.S. currently utilize automated ABG systems that can reduce diagnostic error by almost 26%. Besides, the federal healthcare spending made an allocation of USD 5.5 billion for ABG technologies as of 2023, which is positively impacting the market in the region.

The arterial blood sampling systems market in the U.S. is significantly growing with a 39.5% share, highly attributed to shifts in Medicare policy and expansions in ICU. Besides, automated analyzers constitute an estimated 72% of hospital-based ABG tests, with AI implementation successfully diminishing errors by 28%. Medicaid, in the country, provides coverage services to almost 47% of tests, and point-of-care testing is gradually growing at a 13% rate, propelled by CLIA-waived devices, thus suitable for market upliftment in the country.

The arterial blood sampling systems market in Canada is gaining increased exposure with a growth rate of 6.1%, depending on the presence of provincial healthcare investment strategies. There has been an 18.5% spending hike in Ontario, which has bolstered the adoption of automated analyzers between 2021 and 2024. Besides, public insurance service covers approximately 80% of ABG tests. Moreover, in 2023, federal funding has reached USD 3.3 billion as of 2023 by targeting modernization in the ICU, thereby creating a huge opportunity for market development in the country.

APAC Market Insights

The Asia Pacific is the fastest-growing region in the arterial blood sampling systems market, which is expected to grow at a rate of 8.1% by the end of the forecast period, effectively propelled by government-based health and medical modernization, expansion in hospital facilities, and a rise in the demand for critical care solutions. China is dominating the region with 47% of the overall regional share, further accounting for USD 2.9 billion as of 2023. Meanwhile, India has initiated a surge in spending by 19% in 2023 by targeting shortages in rural ICU admissions. Therefore, all these factors are effectively responsible for positively impacting the market in the region.

The arterial blood sampling systems market growth in China is effectively attributed to the growth in domestic manufacturing processes, along with enormous healthcare infrastructure expansion. The government in the country has made a provision of USD 3.1 billion fund for ABG devices and systems in 2023, which denotes a 15.5% increase within five years. This is further supported by the existence of NMPA fast-tracking acceptances for more than 10 domestic analyzer models in 2024. Besides, more than 72% of tier-3 hospitals can utilize locally produced ABG devices, which has reduced the import dependency by 31.5% under the Made in China 2025 strategy.

The arterial blood sampling systems market in India accounts for 19.5% of the region’s revenue share, which is driven by a rise in respiratory disorders, along with expansion in ICU services. Additionally, the aspect of government spending has reached USD 1.9 billion as of 2023, resulting in an increase of 18.5% in comparison to past years, with the presence of the Ayushman Bharat initiative covering ABG tests for more than 450 million beneficiaries. The regional production is also increasing, with the PLI scheme offering 16.5% subsidies for localized ABG kit manufacturing, thereby suitable for market development.

Government Funding for Arterial Blood Sampling Systems in APAC (2021-2025)

Europe Market Insights

Europe in the arterial blood sampling systems market is projected to expand with a 5.7% growth rate by the end of the forecast duration, which is effectively fueled by EU-wide healthcare digitalization, ICU expansions, and a surge in aging demographics. Germany is leading with 35% of the regional revenue share, which is further attributed to €4.4 billion in yearly expenses as of 2024, along with the presence of stringent sepsis protocols that require ABG testing in almost 92% of ICU cases. Meanwhile, the UK accounts for 24% of the region’s share by providing 8.5% of its NHS budget, thereby bolstering the market in the region.

The arterial blood sampling systems market in Germany is gaining increased traction with progressive MedTech innovation as well as the existence of strict ICU protocols. The country has also allocated €4.7 billion for ABG systems in 2024, of which an estimated 93% has been catered to sepsis management guidelines mandating testing. Besides, the 2024 Hospital Future Act has injected €3.5 billion to digitize ABG workflow, which has escalated the AI-driven analyzers integration that tends to diminish diagnostic timeline by 37%, thus denoting a prolific opportunity for the market in the country.

The arterial blood sampling systems market in the UK is proactively developing, with 23.5% of the region’s market share, effectively supported by the NHS’s £1.3 billion yearly investment, along with an upsurge in point-of-care testing. In addition, sepsis screening mandates in domestic emergency departments have bolstered ABG test volumes by approximately 15% on a yearly basis. Besides, the 2023 MedTech Strategy has readily prioritized affordable automation, with which almost 52% of hospitals are projected to shift to standard analyzers by the end of 2025, thereby denoting an optimistic outlook for the market.